MMP1 and non-small cell lung carcinoma: Clearly, MMP-1 concentration is enhanced in the benign group, abrogating the discrimination from NSCLC, in agreement with the observation of Rosas et al. [26], who propose MMP-1 as a blood marker for Idiophatic Pulmonary Fibrosis (IPF).